[Plasma levels of beta-thromboglobulin and platelet factor 4 in clinical conditions (author's transl)]. 1980

T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010978 Platelet Factor 4 A CXC chemokine that is found in the alpha granules of PLATELETS. The protein has a molecular size of 7800 kDa and can occur as a monomer, a dimer or a tetramer depending upon its concentration in solution. Platelet factor 4 has a high affinity for HEPARIN and is often found complexed with GLYCOPROTEINS such as PROTEIN C. Antiheparin Factor,CXCL4 Chemokine,Chemokine CXCL4,Heparin Neutralizing Protein,PF4 (Platelet Factor 4),gamma-Thromboglobulin,CXCL4, Chemokine,Chemokine, CXCL4,gamma Thromboglobulin
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D004211 Disseminated Intravascular Coagulation A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS. Consumption Coagulopathy,Coagulation, Disseminated Intravascular,Disseminated Coagulation, Intravascular,Intravascular Coagulation, Disseminated,Intravascular Disseminated Coagulation,Coagulation, Intravascular Disseminated,Coagulations, Disseminated Intravascular,Coagulations, Intravascular Disseminated,Coagulopathies, Consumption,Coagulopathy, Consumption,Consumption Coagulopathies,Disseminated Coagulations, Intravascular,Disseminated Intravascular Coagulations,Intravascular Coagulations, Disseminated,Intravascular Disseminated Coagulations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
October 1980, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
October 1980, La Nouvelle presse medicale,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
July 1983, Deutsche medizinische Wochenschrift (1946),
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
February 1988, Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
January 1982, Pharmatherapeutica,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
January 1980, Thrombosis research,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
January 1981, Thrombosis research,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
December 1988, Zhonghua xin xue guan bing za zhi,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
February 1981, Blood,
T Motomiya, and Y Yahara, and Y Onozawa, and C Watanabe, and S Tomura, and T Sano, and H Yamazaki
January 1980, Acta haematologica,
Copied contents to your clipboard!